FDA Approved: PENTOXIFYLLINE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Pentoxifylline submitted by Rising Pharma Holdings, Inc., enabling continued marketing of this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Arterial Disease

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

SUPPL AP for PENTOXIFYLLINE (PENTOXIFYLLINE)